Mannkind Corp MNKD

NAS: MNKD | ISIN: US56400P7069   30/04/2025
5,040 USD (+2,65%)
(+2,65%)   30/04/2025

29 mei 2024 · Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation · Persbericht

11 mei 2023 · Bedrijfsnieuws uit Amerika · Bolero.be

Voor de volledigheid blikken we, voor de start van de opening van New York, nog even terug op het belangrijkste bedrijfsnieuws in Amerika van dinsdag. Disney presteerde in lijn maar stelde teleur met daling aantal Disney+-abonnees...

4 oktober 2021 · MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population · Persbericht

7 september 2021 · United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021 · Persbericht

4 augustus 2021 · NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respiratory Conditions · Persbericht

4 augustus 2021 · MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (aviptadil) Based On The Technosphere® Platform · Persbericht

29 juli 2021 · INDYCAR Driver Conor Daly To Share His Personal Diabetes Story And Race Go-Karts With Local Youth On Wednesday, August 4th · Persbericht

28 juni 2021 · Policy Change Allows Approval For Medicare Patients Living With Diabetes To Use Both Afrezza® And Continuous Glucose Monitoring Devices Beginning July 18 · Persbericht

25 juni 2021 · MannKind Presents Two Posters At American Diabetes Association's Virtual 81st Scientific Sessions, June 25-29 · Persbericht

16 juni 2021 · MannKind And United Therapeutics Achieve A Major Milestone In The Development Of Tyvaso DPI™ With New Drug Application Acceptance From The FDA · Persbericht

16 juni 2021 · United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review · Persbericht

3 juni 2021 · MannKind Announces Data Presentation At 14th International Conference On Advanced Technologies & Treatments For Diabetes (ATTD 2021) To Be Held Virtually June 2-5 · Persbericht

20 mei 2021 · INDYCAR Driver Conor Daly To Share His Personal Diabetes Story And Race Go-karts With Local Youth On Tuesday, May 25th · Persbericht

13 mei 2021 · MannKind Announces Partnership With Type 1 Diabetes IndyCar Driver Conor Daly · Persbericht

24 februari 2021 · Vertice launches THYQUIDITY™ (levothyroxine sodium) Oral Solution · Persbericht

Mijn selecties